Annual Total Liabilities
$1.96 M
-$24.43 M-92.59%
December 31, 2023
Summary
- As of February 26, 2025, TCRT annual total liabilities is $1.96 million, with the most recent change of -$24.43 million (-92.59%) on December 31, 2023.
- During the last 3 years, TCRT annual total liabilities has fallen by -$20.41 million (-91.25%).
- TCRT annual total liabilities is now -97.05% below its all-time high of $66.35 million, reached on December 31, 2015.
Performance
TCRT Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$826.00 K
-$81.00 K-8.93%
September 30, 2024
Summary
- As of February 26, 2025, TCRT quarterly total liabilities is $826.00 thousand, with the most recent change of -$81.00 thousand (-8.93%) on September 30, 2024.
- Over the past year, TCRT quarterly total liabilities has dropped by -$81.00 thousand (-8.93%).
- TCRT quarterly total liabilities is now -99.54% below its all-time high of $180.00 million, reached on June 30, 2016.
Performance
TCRT Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
TCRT Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -92.6% | -8.9% |
| 3 y3 years | -91.3% | -98.2% |
| 5 y5 years | -79.4% | -96.1% |
TCRT Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -94.7% | at low | -97.8% | at low |
| 5 y | 5-year | -94.7% | at low | -98.2% | at low |
| alltime | all time | -97.0% | >+9999.0% | -99.5% | +8594.7% |
Alaunos Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $826.00 K(-8.9%) |
| Jun 2024 | - | $907.00 K(-26.9%) |
| Mar 2024 | - | $1.24 M(-36.6%) |
| Dec 2023 | $1.96 M(-92.6%) | $1.96 M(-64.7%) |
| Sep 2023 | - | $5.54 M(-11.7%) |
| Jun 2023 | - | $6.28 M(-67.2%) |
| Mar 2023 | - | $19.13 M(-27.5%) |
| Dec 2022 | $26.38 M(-28.3%) | $26.38 M(-25.1%) |
| Sep 2022 | - | $35.23 M(+4.4%) |
| Jun 2022 | - | $33.75 M(-5.9%) |
| Mar 2022 | - | $35.87 M(-2.6%) |
| Dec 2021 | $36.81 M(+64.6%) | $36.81 M(-18.3%) |
| Sep 2021 | - | $45.05 M(+143.8%) |
| Jun 2021 | - | $18.48 M(-19.0%) |
| Mar 2021 | - | $22.83 M(+2.1%) |
| Dec 2020 | $22.36 M(+58.6%) | $22.36 M(+6.6%) |
| Sep 2020 | - | $20.98 M(+14.8%) |
| Jun 2020 | - | $18.27 M(+1.8%) |
| Mar 2020 | - | $17.94 M(+27.2%) |
| Dec 2019 | $14.10 M(+48.7%) | $14.10 M(+19.3%) |
| Sep 2019 | - | $11.82 M(+5.8%) |
| Jun 2019 | - | $11.18 M(+20.4%) |
| Mar 2019 | - | $9.29 M(-2.1%) |
| Dec 2018 | $9.49 M(-83.8%) | $9.49 M(-84.9%) |
| Sep 2018 | - | $62.79 M(+2.6%) |
| Jun 2018 | - | $61.19 M(-0.6%) |
| Mar 2018 | - | $61.57 M(+5.4%) |
| Dec 2017 | $58.42 M(+0.2%) | $58.42 M(+2.0%) |
| Sep 2017 | - | $57.29 M(+0.8%) |
| Jun 2017 | - | $56.85 M(-5.2%) |
| Mar 2017 | - | $59.95 M(+2.8%) |
| Dec 2016 | $58.33 M(-12.1%) | $58.33 M(-2.3%) |
| Sep 2016 | - | $59.73 M(-66.8%) |
| Jun 2016 | - | $180.00 M(+181.8%) |
| Mar 2016 | - | $63.87 M(-3.7%) |
| Dec 2015 | $66.35 M(+482.2%) | $66.35 M(-16.6%) |
| Sep 2015 | - | $79.52 M(+484.8%) |
| Jun 2015 | - | $13.60 M(+23.1%) |
| Mar 2015 | - | $11.04 M(-3.1%) |
| Dec 2014 | $11.40 M(-49.1%) | $11.40 M(-9.8%) |
| Sep 2014 | - | $12.63 M(-28.4%) |
| Jun 2014 | - | $17.63 M(-18.3%) |
| Mar 2014 | - | $21.59 M(-3.5%) |
| Dec 2013 | $22.37 M(-36.0%) | $22.37 M(-13.4%) |
| Sep 2013 | - | $25.85 M(-1.6%) |
| Jun 2013 | - | $26.27 M(+3.2%) |
| Mar 2013 | - | $25.45 M(-27.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | $34.96 M(-4.2%) | $34.96 M(-25.0%) |
| Sep 2012 | - | $46.61 M(-0.3%) |
| Jun 2012 | - | $46.74 M(+8.3%) |
| Mar 2012 | - | $43.17 M(+18.3%) |
| Dec 2011 | $36.50 M(+17.9%) | $36.50 M(-4.4%) |
| Sep 2011 | - | $38.16 M(-21.6%) |
| Jun 2011 | - | $48.69 M(-0.4%) |
| Mar 2011 | - | $48.91 M(+57.9%) |
| Dec 2010 | $30.97 M(+43.2%) | $30.97 M(+22.7%) |
| Sep 2010 | - | $25.25 M(+27.9%) |
| Jun 2010 | - | $19.74 M(-42.7%) |
| Mar 2010 | - | $34.45 M(+59.3%) |
| Dec 2009 | $21.63 M(+270.8%) | $21.63 M(+417.5%) |
| Sep 2009 | - | $4.18 M(+11.4%) |
| Jun 2009 | - | $3.75 M(-9.3%) |
| Mar 2009 | - | $4.14 M(-29.1%) |
| Dec 2008 | $5.83 M(-8.2%) | $5.83 M(+1.3%) |
| Sep 2008 | - | $5.76 M(-7.7%) |
| Jun 2008 | - | $6.24 M(-8.1%) |
| Mar 2008 | - | $6.79 M(+6.8%) |
| Dec 2007 | $6.36 M(+113.4%) | $6.36 M(+24.5%) |
| Sep 2007 | - | $5.11 M(+32.0%) |
| Jun 2007 | - | $3.87 M(+13.8%) |
| Mar 2007 | - | $3.40 M(+14.1%) |
| Dec 2006 | $2.98 M(+30.1%) | $2.98 M(-10.3%) |
| Sep 2006 | - | $3.32 M(+24.0%) |
| Jun 2006 | - | $2.68 M(+32.2%) |
| Mar 2006 | - | $2.02 M(-11.6%) |
| Dec 2005 | $2.29 M(+44.1%) | $2.29 M(+31.0%) |
| Sep 2005 | - | $1.75 M(>+9900.0%) |
| Jun 2005 | - | $9900.00(-43.8%) |
| Mar 2005 | - | $17.60 K(-98.9%) |
| Dec 2004 | $1.59 M(+6084.0%) | $1.59 M(>+9900.0%) |
| Sep 2004 | - | $14.90 K(+8.8%) |
| Jun 2004 | - | $13.70 K(-48.3%) |
| Mar 2004 | - | $26.50 K(+3.1%) |
| Dec 2003 | $25.70 K(+44.4%) | $25.70 K(+32.5%) |
| Sep 2003 | - | $19.40 K(+26.8%) |
| Jun 2003 | - | $15.30 K(-33.5%) |
| Mar 2003 | - | $23.00 K(+29.2%) |
| Dec 2002 | $17.80 K(+6.0%) | $17.80 K(+52.1%) |
| Sep 2002 | - | $11.70 K(+15.8%) |
| Jun 2002 | - | $10.10 K(+6.3%) |
| Mar 2002 | - | $9500.00(-43.5%) |
| Dec 2001 | $16.80 K | $16.80 K(+35.5%) |
| Sep 2001 | - | $12.40 K(-13.9%) |
| Jun 2001 | - | $14.40 K |
FAQ
- What is Alaunos Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Alaunos Therapeutics?
- What is Alaunos Therapeutics annual total liabilities year-on-year change?
- What is Alaunos Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Alaunos Therapeutics?
- What is Alaunos Therapeutics quarterly total liabilities year-on-year change?
What is Alaunos Therapeutics annual total liabilities?
The current annual total liabilities of TCRT is $1.96 M
What is the all time high annual total liabilities for Alaunos Therapeutics?
Alaunos Therapeutics all-time high annual total liabilities is $66.35 M
What is Alaunos Therapeutics annual total liabilities year-on-year change?
Over the past year, TCRT annual total liabilities has changed by -$24.43 M (-92.59%)
What is Alaunos Therapeutics quarterly total liabilities?
The current quarterly total liabilities of TCRT is $826.00 K
What is the all time high quarterly total liabilities for Alaunos Therapeutics?
Alaunos Therapeutics all-time high quarterly total liabilities is $180.00 M
What is Alaunos Therapeutics quarterly total liabilities year-on-year change?
Over the past year, TCRT quarterly total liabilities has changed by -$81.00 K (-8.93%)